Skip to main content

Advertisement

Log in

JAKing up immunosuppression

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A new immunosuppressive agent makes its debut in primate models of kidney transplantation. The drug has the potential to join the ranks of immunosuppressants currently used in transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Limiting the lymphocyte.

Kimberly Homer

References

  1. Kung, L. et al. Am. J. Transplant. 1, 325–333 (2001).

    Article  CAS  Google Scholar 

  2. Changelian, P.S. et al. Science 302, 875–878 (2003).

    Article  CAS  Google Scholar 

  3. O'Shea, J.J. Immunity 7, 1–11 (1997).

    Article  CAS  Google Scholar 

  4. Leonard, W.J. Annu. Rev. Med. 47, 229–239 (1996).

    Article  CAS  Google Scholar 

  5. Spitzer, T.R. et al. Transplantation 68, 480–484 (1999).

    Article  CAS  Google Scholar 

  6. Lakkis, F.G. & Dai, Z. Curr. Opin. Immunol. 11, 504–508 (1999).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sykes, M. JAKing up immunosuppression. Nat Med 9, 1458–1459 (2003). https://doi.org/10.1038/nm1203-1458

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1203-1458

  • Springer Nature America, Inc.

Navigation